HomeOMND • CNSX
add
Optimind Pharma Corp
Previous close
$0.0050
Year range
$0.0050 - $0.010
Market cap
548.94K CAD
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Nov 2025info | Y/Y change |
|---|---|---|
Revenue | 34.02K | 28.12% |
Operating expense | 34.69K | 54.00% |
Net income | -28.62K | -216.49% |
Net profit margin | -84.11 | -147.02% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Nov 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 93.91K | -8.45% |
Total assets | 191.55K | -10.03% |
Total liabilities | 300.33K | 15.05% |
Total equity | -108.78K | — |
Shares outstanding | 103.15M | — |
Price to book | ∞ | — |
Return on assets | -24.30% | — |
Return on capital | -185.43% | — |
Cash Flow
Net change in cash
| (CAD) | Nov 2025info | Y/Y change |
|---|---|---|
Net income | -28.62K | -216.49% |
Cash from operations | -23.18K | -290.50% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -23.18K | -290.50% |
Free cash flow | -6.69K | -139.45% |
About
Founded
2008
Headquarters
Website
